(4-[3-(Trifluoromethyl)phenoxy]phenyl)boranediol, 95%, 500mg

4-Amino-3,5,6-trichloropyridine-2-carboxylic acid, 97.0%, 5g

Bucladesine Sodium Salt>97.0%(HPLC)25mg

2-Bromo-1-(4-chloro-1-methyl-1H-pyrazol-3-yl)ethanone, 97.0%, 100mg

(R)-1-(2-Fluorophenyl)ethylamine hydrochloride, 95.0%, 5g

4-Chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, 95.0%, 5g

(+)-Vinylboronic acid pinanediol ester, 98% mix TBC as stabilizer, 1g

methyl 2-(2-imino-5,6-dimethoxybenzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 1g

N-(5-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PYRIDIN-2-YL)-2,5-DIOXO-1-PHENYL-1,2,5,6,7,8-HEXAHYDROQUINOLINE-3-CARBOXAMIDE, 95%, 250mg

Ethyl picolinoylacetate, 95.0%, 25g

9-([1,1'-Biphenyl]-4-yl)-9'-phenyl-9H,9'H-3,3'-bicarbazole, 95%, 1g

2-(2-Propenyl)benzoic acid, 97.0%, 1g

Base libre de naranja de acridina (CI 46005) para microscopía, 5 g, envase de vidrio